Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ASND
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Ascendis Pharma A/S (ASND) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Ascendis Pharma (ASND) trades at $270.09, down 0.17% on the day, with a bullish technical signal from moving averages and strong analyst support. Revenue surged to $720.13 million in 2025, with net losses narrowing to -$228.03 million, while recent Q2 2026 earnings beat expectations. The company's settlement with BioMarin resolves patent disputes, and inclusion in Russell indexes boosts visibility.
Outlook is positive with a consensus price target of $317.73, driven by robust revenue growth and pipeline progress, but risks include high debt levels and reliance on rare disease drug commercialization. Investors should weigh strong institutional sentiment against execution challenges in a competitive biotech landscape.
Read full analysis

Key Stats

  • Market Cap
    $17.75B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $277.18
  • 52W Low
    $189.74
  • Typical Hold Time
    -
  • Enterprise Value
    $17.33B
  • Div Yield
    -
  • Trading Activity
    -
$272.19
52W Low: $189.74
25 Sep 2025
52W High: $277.18
08 Jul 2026

Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $189.74 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Most Recent News

Content is generated by Aura AI

Disc Medicine faces class action over alleged misleading FDA drug approval info causing 22% stock drop.

Rosen Law Firm is investigating a class action lawsuit against Disc Medicine, Inc. after the FDA issued a Complete Response Letter rejecting the company's new drug application for bitopertin due to uncertainties requiring more evidence. This announce...

Market News
4 hours ago
Newsfile Corp
Bearish
news icon
Disc Medicine faces class action over alleged misleading FDA drug approval info causing 22% stock drop.

China's inflation rises as producer prices jump 3.8%, signaling cost pressures despite weak consumer demand.

China's producer price index rose 3.8% in August, surpassing forecasts and July's 3.5%, driven by higher global commodity prices and strong demand in high-tech sectors. Consumer inflation also accelerated to 0.8% year-on-year, reflecting seasonal foo...

Market News
5 hours ago
CNBC
Neutral
China's inflation rises as producer prices jump 3.8%, signaling cost pressures despite weak consumer demand.

On Semiconductor poised for growth with $213B TAM upgrade and Synaptics acquisition ahead of Investor Day 2026

On Semiconductor (ON) is set for a potential re-rating driven by a massive total addressable market (TAM) upgrade to $213 billion by 2030, boosted by its $7 billion acquisition of Synaptics which expands its TAM by 233%. Despite a 12-14% shareholder ...

Market News
5 hours ago
Seeking Alpha
Bullish
news icon
On Semiconductor poised for growth with $213B TAM upgrade and Synaptics acquisition ahead of Investor Day 2026
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $17.75B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $277.18
  • 52W Low
    $189.74
  • Typical Hold Time
    -
  • Enterprise Value
    $17.33B
  • Div Yield
    -
  • Trading Activity
    -
$272.19
52W Low: $189.74
25 Sep 2025
52W High: $277.18
08 Jul 2026

Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $189.74 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!